My Companies
Notification
Account
Log Out
Login
Board approved a fundraise of up to 51 Cr for business expansion. The funding consists of a 35 Cr preferential allotment, 10 Cr in debt, and 6 Cr via internal accruals. The Managing Director was authorized to finalize investors. The proposal is subject to shareholder and regulatory approvals.
Aptus Pharma Approves ₹44.88 Crore Raise For Manufacturing Expansion
Aptus Pharma Approves ₹44.88 Crore Preferential Issue At ₹280
Aptus Pharma Approves 16.1 Lakh-Share Preferential Issue To 192 Investors